Xencor Alternatives & Competitors
12 companies similar to Xencor — Proteins by Design
Companies similar to Xencor
Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious...
Canada
Attovia Therapeutics
Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...
San Carlos, United States
Solu Therapeutics
Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...
Boston, United States
Alector
We are on a mission to make brain disorders history.
South San Francisco, Unit...
Rival Readout
Competing with Xencor? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
Bright Peak Therapeutics
Better Biologics Through Chemistry
Basel, Switzerland
Merus N.V.
Merus was acquired by Genmab. To see what’s new, visit Genmab.
Utrecht, The Netherlands
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Biotheus Inc.
To Inspire Each Other and Create Effective Medicines for Humankind
Zhuhai, China
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
About Xencor
Xencor, founded in 1997, is at the forefront of the biotechnology sector, revolutionizing treatments for autoimmune diseases, asthma, and cancer through cutting-edge biotherapeutics. Their slogan, "Proteins by Design", encapsulates their innovative approach towards protein engineering. Leveraging their proprietary XmAb...
Design and development of bispecific antibody drugs, Strategic collaborations with pharmaceutical companies, Extensive clinical and preclinical drug pipeline, Customization of antibodies using XmAb protein engineering platform
Pharmaceutical companies interested in drug development partnerships, Investors seeking opportunities in biotechnology and life sciences, Healthcare professionals focused on cancer and serious disease therapeutics, Scientific research communities involved in antibody and protein engineering
Protein Engineering, Antibody Therapeutics, Biotherapeutics, Autoimmune Disease Treatment, Oncology, Asthma Treatment, B Cell Malignancies, Hodgkin's Lymphoma, Myeloma Treatment, Biosuperiors, Monoclonal Antibodies, Bispecific Antibodies, Drug Development, Cytokines, Neuroinflammatory Diseases
B2B, B2B2B, API
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Xencor: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Xencor on 9 Jun 2026. The 12 companies listed here were last checked between 25 Mar 2025 and 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
